Bumper Offer - Urjas oil Just @ Rs. 1
Metolar 50 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. High BP are some of its major therapeutic uses. Metolar 50 Mg Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Metolar 50 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Metolar 50 Mg Tablet include Slow heart rate (pulse). Some other side effects of Metolar 50 Mg Tablet have been listed ahead. These side effects of Metolar 50 Mg Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Metolar 50 Mg Tablet's effect is Severe during pregnancy and Mild for lactating mothers. Warnings related to Metolar 50 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Metolar 50 Mg Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate) as it can result in adverse effects. Other contraindications of Metolar 50 Mg Tablet have been discussed in the sections ahead.
Besides this, Metolar 50 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Metolar 50 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Metolar 50 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Metolar 50 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Metolar 50 Mg Tablet safe for pregnant women?
Metolar has many dangerous side effects in pregnant women. If you are pregnant, do not consume Metolar without medical advice.
Is the use of Metolar 50 Mg Tablet safe during breastfeeding?
Metolar may have very limited harmful effects for breastfeeding women.
What is the effect of Metolar 50 Mg Tablet on the Kidneys?
Metolar is completely safe for kidneys.
What is the effect of Metolar 50 Mg Tablet on the Liver?
Metolar is rarely harmful for the liver.
What is the effect of Metolar 50 Mg Tablet on the Heart?
Metolar is rarely harmful for the heart.
Metolar 50 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Metolar 50 Mg Tablet unless your doctor advises you to do so -
Is this Metolar 50 Mg Tablet habit forming or addictive?
Metolar 50 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Metolar 50 Mg Tablet, you should not drive or work on any heavy machine, as Metolar 50 Mg Tablet can make you drowsy.
Is it safe?
Yes, but consume Metolar 50 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Metolar 50 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Metolar 50 Mg Tablet
When consumed with certain foods, Metolar 50 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Metolar 50 Mg Tablet
Consumption of alcohol and Metolar 50 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
